Market Overview

Benzinga's Top #PreMarket Gainers

Related FRX
Activis Shares Languish Post-Forest Deal
Among A Raft Of Index Changes, Affiliated Managers Group To Join S&P 500
ValueWalk On What Might Be Pershing Square's 'Big Secret Short'
Actavis' Growth 'Underappreciated,' Sterne Agee Says
Actavis' Xydalba Granted Marketing Authorisation in Europe - Analyst Blog (Zacks)

Forest Laboratories (NYSE: FRX) surged 34.46% to $95.99 in the pre-market session after Actavis (NYSE: ACT) announced its plans to buy Forest Labs for $25 billion. Analysts at Morgan Stanley upgraded Forest Labs from Equal-Weight to Overweight.

Actavis plc (NYSE: ACT) soared 12.04% to $215.00 in the pre-market trading on deal for Forest Laboratories (NYSE: FRX).

Insmed (NASDAQ: INSM) shares jumped 8.42% to $18.15 in pre-market trading after dropping 0.78% on Friday.

BlackBerry (NASDAQ: BBRY) shares gained 4.90% to $9.42 in the pre-market on report of Loeb 10 million share stake. FBR Capital upgraded BlackBerry from Underperform to Market Perform.

Posted-In: PreMarket GainersNews Pre-Market Outlook Markets Movers


Related Articles (BBRY + ACT)

Around the Web, We're Loving...

Get Benzinga's Newsletters